Association Between Low Sex Hormone–Binding Globulin and Increased Risk of Type 2 Diabetes Is Mediated by Increased Visceral and Liver Fat: Results From Observational and Mendelian Randomization Analyses.

The aim of this study was to investigate the associations among sex hormone–binding globulin (SHBG), visceral adipose tissue (VAT), liver fat content, and risk of type 2 diabetes (T2D). In the Netherlands Epidemiology of Obesity study, 5,690 women (53%) and men (47%) without preexisting diabetes were included and followed for incident T2D. SHBG concentrations were measured in all participants, VAT was measured using MRI, and liver fat content was measured using proton magnetic resonance spectroscopy in a random subset of 1,822 participants. We examined associations between SHBG and liver fat using linear regression and bidirectional Mendelian randomization analyses and between SHBG and T2D using Cox regression adjusted for confounding and additionally for VAT and liver fat to examine mediation. Mean age was 56 (SD 6) years, mean BMI was 30 (SD 4) kg/m2, median SHBG was 47 (interquartile range [IQR] 34–65) nmol/L in women and 34 (26–43) nmol/L in men, and median liver fat was 3.4% (IQR 1.6–8.2%) in women and 6.0% (2.9–13.5%) in men. Compared with the highest SHBG quartile, liver fat was 2.9-fold (95% CI 2.4, 3.4) increased in women and 1.6-fold (95% CI 1.3, 1.8) increased in men, and the hazard ratio of T2D was 4.9 (95% CI 2.4, 9.9) in women and 1.8 (1.1, 2.9) in men. Genetically predicted SHBG was associated with liver fat content (women: SD −0.45 [95% CI −0.55, −0.35]; men: natural logarithm, −0.25 [95% CI −0.34, −0.16]). VAT and liver fat together mediated 43% (women) and 60% (men) of the SHBG-T2D association. To conclude, in a middle-aged population with overweight, the association between low SHBG and increased risk of T2D was, for a large part, mediated by increased VAT and liver fat. Article Highlights: The objective of this study was to unravel the associations between sex hormone–binding globulin (SHBG) and type 2 diabetes (T2D). The extent to which the association between low SHBG and increased risk of T2D was mediated by visceral adipose tissue (VAT) and liver fat was examined. VAT and liver fat were found to mediate a large part of the association between SHBG and T2D. Both lifestyle and medical interventions that increase SHBG may reduce VAT, liver fat, and the risk of T2D. [ABSTRACT FROM AUTHOR]